MATSUDA MASARU (SVP and General Counsel) sold 8.1% of their position (12.06K shares) of ARCUTIS BIOTHERAPEUTICS, INC. on the open market
Open‑market sale worth $313.9K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 4 sales
Filed: 3/3/2026ACC: 0001628280-26-014326
Officer· SVP and General Counsel
Since Jan 2022
+121.94K
Net shares
Net buyer
$313.9K
Total sold
4
Open market trades
0B · 4S
6
Total transactions
134K acquired · 12.06K disposed
Non-Derivative Transactions5
Common Stock
Direct
Shares
+37K
Price / share
—
Trade value
—
% of position
33.6%
2/27/2026
110K→147K
Common Stock
Direct
Shares
−3.33K
Price / share
$27.95
Trade value
$92.93K
% of position
2.3%
2/27/2026
147K→143.68K
Common Stock
Direct
Shares
−6.55K
Price / share
$25.16
Trade value
$164.88K
% of position
4.6%
3/2/2026
143.68K→137.13K
Common Stock
Direct
Shares
−193.00
Price / share
$25.91
Trade value
$5K
% of position
0.1%
3/2/2026
137.13K→136.93K
Common Stock
Direct
Shares
−1.99K
Price / share
$25.70
Trade value
$51.07K
% of position
1.4%
3/2/2026
138.92K→136.93K
Total
Net shares
+24.94K
Net value
-$313.88K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 2/27/2026 | A · Award | +37K | — | — | 33.6% | 110K | 147K |
| Common Stock Direct | 2/27/2026 | S · Sale | −3.33K | $27.95 | $92.93K | 2.3% | 147K | 143.68K |
| Common Stock Direct | 3/2/2026 | S · Sale | −6.55K | $25.16 | $164.88K | 4.6% | 143.68K | 137.13K |
| Common Stock Direct | 3/2/2026 | S · Sale | −193.00 | $25.91 | $5K | 0.1% | 137.13K | 136.93K |
| Common Stock Direct | 3/2/2026 | S · Sale | −1.99K | $25.70 | $51.07K | 1.4% | 138.92K | 136.93K |
| Total | +24.94K | -$313.88K | ||||||
Derivative Transactions1
Stock Option (right to buy)
Direct
Converts to
Common Stock
97K shares
Shares
+97K
Strike price
26.97
Held after
97K
Exercisable
—
2/27/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (right to buy) Direct | Common Stock97K shares | 2/27/2026 | A · Award | +97K | 26.97 | — | 97K |